跳至主要内容
临床试验/EUCTR2009-010280-17-DK
EUCTR2009-010280-17-DK进行中(未招募)不适用

TS HYPE - Turner syndrome and Hypertension; a double-blinded randomised interventional trial.

Organisation name was not entered0 个研究点目标入组 120 人开始时间: 2009年2月25日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • 1.TS as verified through chromosomal genotyping.
  • 2.Age > 18 years.
  • 3.Hypertension defined as: a) 24-hour ambulatory blood pressure with 24-hour blood pressure > 118/75 mmHg, daytime values > 125/80 mmHg, and/or: night-time values > 102/66 mmHg 28, 29. b) Hypertension as documented with earlier clinical or ambulatory hypertension by a medical doctor with subsequent commencement anti-hypertensive medications.
  • 4.Expected stationary status of either ongoing or absent oral oestrogen substitution therapy (HRT).
  • 5.Informed consent – in writing and orally, as well as written authority.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. Contraindication to performing MR scans:
  • a)Claustrophobia,
  • b)Magnetic or electric foreign bodies – including; cardiac pacemakers, magnetic cerebrovascular clips and electric non-removable appliances dosing medicine and/or:
  • c)Extreme adiposity (BMI > 35 kg/m2).
  • 2. Contraindication to BB therapy
  • a)Allergy to the ingredients,
  • b)Significant bradycardia or advanced atrioventricular block,
  • c)Decompensated heart failure and/or:
  • d)Asthma bronchiale.
  • 3. Contraindications to ARB therapy:
  • a)Allergy to the ingredients,
  • b)Pregnancy, and/or:
  • c)Known renal artery stenosis, severe renal insufficiency.
  • d)Severe hepatic failure, biliary cirrhosis and cholestasis
  • 4. Mechanical aortic valve or aortic prosthesis
  • 5. Former or present malignant disease.
  • 6. Diagnosed chronic liver disease (hepatitis or cirrhosis), as elevated liver enzymes are a common finding regarded as non-specific.
  • 7. Other severe acute or chronic disease of known or presumed influence on the parameters of the study.

研究者

发起方
Organisation name was not entered

相似试验